In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Cancer cells on a screen
Making Progress Against Metastasis

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.
A women sitting in a chair holding a bell
Top Cancer Treatment Advances at MSK in 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Pictured: American Association of Cancer Research Annual Meeting 2012
Announcement
Memorial Sloan Kettering Discoveries in Personalized Medicine Highlighted at Major Cancer Research Meeting; Investigators Honored

The American Association for Cancer Research (AACR), the world's oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.
MSK neuro-oncologist Adrienne Boire and computational biologist Dana Pe’er with a male patient in a laboratory.
Article
Leptomeningeal Metastasis (LM) Clinical Trial Offers Treatment for Stage 4 Lung Cancer Patient

Read about a new treatment for leptomeningeal metastasis that is giving patients hope.
Dr. Elli Papaemmanuil in her lab
Why Clonal Hematopoiesis, a Blood Condition Related to Aging, Is Linked to Worse Outcomes for Cancer Patients

Researchers have shown how CH, a blood condition related to aging, affects cancer outcomes — through a phenomenon called tumor-infiltrating clonal hematopoiesis.
Dr. Rona Yaeger
FDA Approves First Colorectal Cancer Treatment that Targets G12C KRAS Gene

The targeted therapy adagrasib received accelerated approved for colorectal cancer caused by a mutation called KRAS-G12C, when used in combination with the drug cetuximab. MSK investigators have led much of the research that resulted in this combined drug approval.
Adrienne Boire at the lab bench
In the Lab
Inspired by a Patient, a Doctor Finds Answers for a Devastating Cancer Complication

Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.
Colored x-ray of lung cancer
In the Lab
New Lung Cancer Therapy May Target Previously Untreatable Tumors

Researchers are developing uses for a drug that could benefit many people with lung cancer.